Literature DB >> 6316883

Low density lipoprotein metabolism by endothelial cells from human umbilical cord arteries and veins.

V W van Hinsbergh, L Havekes, J J Emeis, E van Corven, M Scheffer.   

Abstract

Binding and metabolism of low density lipoprotein (LDL) and acetylated LDL were examined in endothelial cells from human umbilical cord arteries and veins. Both high and low affinity LDL interactions were observed. High affinity LDL binding and catabolism were increased five- to sevenfold after preincubation for 18 hours in LPDS containing medium. Subconfluent cells degraded, endocytosed, and bound 1.5 to 2.7 times more LDL by high affinity interaction than confluent cells, when endothelial cell growth supplement (ECGS) was present in the culture system. In the absence of ECGS, these ratios were somewhat less. Low affinity LDL metabolism was less affected by the state of confluency. Binding of LDL and acetylated LDL by venous endothelial cells was more than two- and threefold, respectively, than that by comparable arterial cells. However, the difference in LDL binding was not reflected in an altered LDL catabolism. There apparently is a population of low affinity binding sites not involved in LDL catabolism. LDL metabolism was identical in cells, which were cultured in medium supplemented with 20% to 100% serum or hirudin- or heparin-treated platelet-poor plasma. Without preincubation in LPDS, high affinity adsorptive endocytosis mediated the main part of LDL uptake only at low LDL concentrations (5 to 20 micrograms protein/ml). However, at physiological LDL concentrations (550 micrograms/ml), we estimated that this process mediated only 17% of the LDL uptake. We calculated that fluid endocytosis and low affinity adsorptive endocytosis of LDL accounted for the remaining 12% and 70%, respectively, of the LDL uptake at physiological LDL concentrations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6316883     DOI: 10.1161/01.atv.3.6.547

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  16 in total

1.  Butyrate stimulates tissue-type plasminogen-activator synthesis in cultured human endothelial cells.

Authors:  T Kooistra; J van den Berg; A Töns; G Platenburg; D C Rijken; E van den Berg
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

2.  Effect of propionyl-L-carnitine on human endothelial cells.

Authors:  V W van Hinsbergh; M A Scheffer
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

3.  Quantification of tissue-type plasminogen activator (t-PA) mRNA in human endothelial-cell cultures by hybridization with a t-PA cDNA probe.

Authors:  A J van Zonneveld; G T Chang; J van den Berg; T Kooistra; J H Verheijen; H Pannekoek; C Kluft
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

Review 4.  Emerging Roles of Vascular Endothelium in Metabolic Homeostasis.

Authors:  Xinchun Pi; Liang Xie; Cam Patterson
Journal:  Circ Res       Date:  2018-08-03       Impact factor: 17.367

5.  Pharmacological blockade of cholesterol trafficking by cepharanthine in endothelial cells suppresses angiogenesis and tumor growth.

Authors:  Junfang Lyu; Eun Ju Yang; Sarah A Head; Nana Ai; Baoyuan Zhang; Changjie Wu; Ruo-Jing Li; Yifan Liu; Chen Yang; Yongjun Dang; Ho Jeong Kwon; Wei Ge; Jun O Liu; Joong Sup Shim
Journal:  Cancer Lett       Date:  2017-09-18       Impact factor: 8.679

6.  Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds.

Authors:  R O Schlingemann; F J Rietveld; R M de Waal; S Ferrone; D J Ruiter
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

7.  Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation.

Authors:  J Arts; M Lansink; J Grimbergen; K H Toet; T Kooistra
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

8.  Metabolism by human endothelial cells of very low density lipoprotein subfractions isolated from type 1 (insulin-dependent) diabetic patients.

Authors:  R L Klein; M F Lopes-Virella
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

9.  Mouse adenovirus type 1-induced breakdown of the blood-brain barrier.

Authors:  Lisa E Gralinski; Shanna L Ashley; Shandee D Dixon; Katherine R Spindler
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

10.  Low-density lipoproteins are degraded in HepG2 cells with low efficiency.

Authors:  P Lombardi; M Mulder; E de Wit; T J van Berkel; R R Frants; L M Havekes
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.